FDA proposes risk-based LDT regulation

FDA (see BioCentury Extra, July 17).

FDA released the pre-draft guidance to fulfill a requirement under the Food and Drug Administration Safety and Innovation Act, which requires the agency to notify Congress 60 days prior to publishing draft guidance on LDT regulation. FDA will not publish the draft or open a public docket for at least 60 days. ...